Famciclovir clinical trials
Also written Famvir.
How each study uses Famciclovir is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- 29 Jun 1994 · FAMVIR · NDA 020363 (FDA, Drugs@FDA)
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
18 studies that test it; most in 2007 (4)
| Year | Studies |
|---|---|
| 2003 | 3 |
| 2004 | 3 |
| 2005 | 2 |
| 2006 | 1 |
| 2007 | 4 |
| 2009 | 1 |
| 2011 | 1 |
| 2012 | 2 |
| 2020 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 16 · Other 2
Novartis (7) · Novartis Pharmaceuticals (3) · Teva Pharmaceuticals USA (2) · EMS (2) · Roxane Laboratories (2) · House Research Institute (1) · Queen Mary University of London (1)
Studies
Open first, then newest update. How each study uses Famciclovir is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 18
- Famciclovir 500 mg Tablets Under Non-Fasting ConditionsCompletedPhase 1Teva Pharmaceuticals USANCT00834444Written as Famciclovir 500 mg TabletsHow we know
- Famciclovir 500 mg Tablets Under Fasting ConditionsCompletedPhase 1Teva Pharmaceuticals USANCT00834431Written as Famciclovir 500 mg TabletsHow we know
- Famciclovir in Multiple SclerosisStatus unknownPhase 2Queen Mary University of LondonNCT05283551Written as FamciclovirHow we know
- Safety and Pharmacokinetics of Famciclovir Single 1500 mg Dose in Adolescents With Recurrent Herpes LabialisCompletedPhase 2/3Novartis PharmaceuticalsNCT00878072Written as FamciclovirHow we know
- Efficacy of Oral Famciclovir 125mg Comparing to Aciclovir 200 mg Treatment in Patients With Active Recurrent Genital HerpesCompletedPhase 3EMSNCT01281007Written as FamciclovirHow we know
- Famvir for Treatment of Hearing in Unilateral Meniere's DiseaseTerminatedPhase 3House Research InstituteNCT01526408Written as FamciclovirHow we know
- Efficacy of Oral Famciclovir Versus Aciclovir Treatment in Patients With Herpes ZosterCompletedPhase 3EMSNCT01327144Written as FamciclovirHow we know
- Bioequivalency Study of Famciclovir 500 mg Tablets Under Fed ConditionsCompletedNot applicableRoxane LaboratoriesNCT01321502Written as famciclovirHow we know
- Bioequivalency Study of Famciclovir 500 mg Tablets Under Fasted ConditionsCompletedNot applicableRoxane LaboratoriesNCT01321515Written as famciclovirHow we know
- Efficacy and Safety of Oral Famciclovir in Patients With Active Recurrent Genital HerpesCompletedPhase 3NovartisNCT00171990Written as FamciclovirHow we know
- Famciclovir Pediatric Formulation in Children 1 to 12 Years of Age With Herpes Simplex InfectionCompletedPhase 3Novartis PharmaceuticalsNCT00098059Written as FamciclovirHow we know
- RELIEF: Randomized Episodic Versus Long-Term Suppression Experience With FamciclovirCompletedPhase 4NovartisNCT00219310Written as FamciclovirHow we know
- A Study to Evaluate the Effect of Famciclovir in Reducing Herpes Virus SheddingCompletedPhase 4NovartisNCT00129818Written as FamciclovirHow we know
- Efficacy and Safety of Famciclovir 1-day Treatment Compared to 3-day Treatment With Valacyclovir in Adults With Recurrent Genital HerpesCompletedPhase 3Novartis PharmaceuticalsNCT00306787Written as FamciclovirHow we know
- Patient-initiated Episodic Treatment of Recurrent Genital Herpes in Black PatientsCompletedPhase 4NovartisNCT00477334Written as FamciclovirHow we know
- Pharmacokinetics, Acceptability and Safety of Famciclovir in Infants (1 Month to Less Than 12 Months) With Herpes Simplex InfectionCompletedPhase 2NovartisNCT00448227Written as famciclovirHow we know
- A Study to Evaluate the Safety and Efficacy of Single Day or Single Dose Famciclovir for the Treatment of Recurrent Herpes LabialisCompletedPhase 4NovartisNCT00248144Written as FamciclovirHow we know
- Famciclovir Oral Pediatric Formulation in Children 1-12 Years of Age With Varicella Zoster InfectionCompletedPhase 3NovartisNCT00098046Written as famciclovirHow we know
Given beside what is tested · 1 — Famciclovir is usual care or a partner of the new treatment
As the comparator · 1 — what is tested is compared with Famciclovir
Codes
What other systems call Famciclovir · ClinicalTrials.gg INT006769
- MeSH (NLM) D000077595FamciclovirConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) QIC03ANI02FAMCICLOVIRConfirmed FDA, NLM, Wikidata
- RxNorm 68099Confirmed FDA, Wikidata
- Wikidata Q420186famciclovirConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C29044FamciclovirOne source FDA
- DrugBank DB00426One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D000077595 | Famciclovir | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | QIC03ANI02 | FAMCICLOVIR | Confirmed FDA, NLM, Wikidata |
| RxNorm | 68099 | — | Confirmed FDA, Wikidata |
| Wikidata | Q420186 | famciclovir | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C29044 | Famciclovir | One source FDA |
| DrugBank | DB00426 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.